- Clear All
- Remove thePharmacologyfilter Pharmacology
- Remove theAnimal healthfilter Animal health
- Remove thePractice operationsfilter Practice operations
- Remove theOrganized veterinary medicinefilter Organized veterinary medicine
- Remove theAnimal diseasesfilter Animal diseases
- Remove theAVMA policyfilter AVMA policy
blog
AVMA endorses federal legislation to address illicit xylazine
The bill would equip law enforcement with additional tools to stop illegal xylazine trafficking while protecting veterinarians’ access to this…
policy
The veterinary profession's role in addressing the opioid epidemic
AVMA strongly recommends that veterinarians, legislators, state veterinary medical boards, and state pharmacy boards work together to create practical…
resource
AVMA request: Commenting deadline for compounding
JAVMA news
International joint statements address horse slaughter, rabies in dogs
The AVMA has adopted a joint statement on horse slaughter with the Canadian and Mexican veterinary associations and a joint statement on rabies in…
Council on Biologic and Therapeutic Agents
The Council on Biologic and Therapeutic Agents advises the Board of Directors in promoting interest in the efficacy and proper use of biologic and…
Committee on Antimicrobials
The Committee on Antimicrobials supports AVMA’s strategy to allow the veterinary profession to effectively share robust and comprehensive…
JAVMA news
Marijuana treatments, drug monitoring programs discussed
AVMA House of Delegates members want the Association to develop policies and further guidance on emerging issues affecting the profession, such as…
JAVMA news
States track dispensing to counter drug fraud
A third of states and the District of Columbia require reports from veterinarians when they dispense controlled substances
JAVMA news
Groups provide new guidance on antimicrobials
The AVMA, Canadian VMA, and Federation of Veterinarians of Europe are calling for continuous monitoring of antimicrobial use and resistance at a…
JAVMA news
FDA describes legal limits of drug compounding
Agency says few uses allowed for raw active ingredients